Insurer Fends Off Genzyme's Bid For Coverage
Genzyme Corp. has lost a fight with its insurer over who should pick up the tab for a securities class action the biotechnology company settled with investors two years ago....To view the full article, register now.
Already a subscriber? Click here to view full article